Back to mobile site

Guggenheim Assumes Sangamo BioSciences (SGMO) at Neutral

January 6, 2021 4:21 PM EST Send to a Friend
Guggenheim analyst Debjit Chattopadhyay assumes coverage on Sangamo BioSciences (NASDAQ: SGMO) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login